Editorial: Heart valve diseases: from molecular mechanisms to clinical implications.
作者信息
Ibarrola Jaime, Lopez-Andres Natalia
机构信息
Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA, United States.
Cardiovascular Translational Research, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
出版信息
Front Mol Med. 2023 Jul 28;3:1260912. doi: 10.3389/fmmed.2023.1260912. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: Heart valve diseases: from molecular mechanisms to clinical implications.社论：心脏瓣膜疾病：从分子机制到临床意义
Front Mol Med. 2023 Jul 28;3:1260912. doi: 10.3389/fmmed.2023.1260912. eCollection 2023.
2
A systematic review of the cost-effectiveness of heart valve replacement with a mechanical versus biological prosthesis in patients with heart valvular disease.心脏瓣膜疾病患者采用机械瓣膜与生物瓣膜置换的成本效益的系统评价。
Heart Fail Rev. 2020 May;25(3):495-503. doi: 10.1007/s10741-019-09897-9.
3
Rate, Timing, Correlates, and Outcomes of Hemodynamic Valve Deterioration After Bioprosthetic Surgical Aortic Valve Replacement.生物瓣外科主动脉瓣置换术后血流动力学瓣膜恶化的发生率、时间、相关性和结局。
Circulation. 2018 Sep 4;138(10):971-985. doi: 10.1161/CIRCULATIONAHA.118.035150.
4
Serotonin contribution to cardiac valve degeneration: new insights for novel therapies?血清素对心脏瓣膜退行性变的影响：新型治疗方法的新见解？
Pharmacol Res. 2019 Feb;140:33-42. doi: 10.1016/j.phrs.2018.09.009. Epub 2018 Sep 9.
5
Hemodynamic Deterioration of Surgically Implanted Bioprosthetic Aortic Valves.外科植入生物瓣主动脉瓣的血液动力学恶化。
J Am Coll Cardiol. 2018 Jul 17;72(3):241-251. doi: 10.1016/j.jacc.2018.04.064. Epub 2018 Jul 9.
6
What do we know about the cardiac valve lesion in the antiphospholipid syndrome (APS)?我们对抗磷脂综合征（APS）中的心脏瓣膜病变了解多少？
Lupus. 2014 Oct;23(12):1259-61. doi: 10.1177/0961203314534307.
7
Estimating the Potential Economic Impact of Tissue Valve Replacement for Heart Valve Disease in China: Patient-Level and Population-Level Cost-Benefit Simulation Analyses.评估中国心脏瓣膜病组织瓣膜置换的潜在经济影响：患者层面和群体层面的成本效益模拟分析。
Value Health Reg Issues. 2023 May;35:19-26. doi: 10.1016/j.vhri.2023.01.002. Epub 2023 Feb 17.
8
Heart valve disease in primary antiphospholipid syndrome.原发性抗磷脂综合征中的心脏瓣膜病
Rheumatology (Oxford). 2024 May 2;63(5):1397-1402. doi: 10.1093/rheumatology/kead399.
9
The impact of hypo-attenuated leaflet thickening on haemodynamic valve deterioration following transcatheter aortic valve replacement.经导管主动脉瓣置换术后低回声瓣叶增厚对血液动力学瓣膜恶化的影响。
J Cardiovasc Comput Tomogr. 2022 Mar-Apr;16(2):168-173. doi: 10.1016/j.jcct.2021.11.013. Epub 2021 Nov 26.
10
Developing Hemodynamic Valve Deterioration and Mortality in Aortic Valve Replacement.主动脉瓣置换术中血流动力学瓣膜退变及死亡率的发展
J Surg Res. 2023 May;285:236-242. doi: 10.1016/j.jss.2022.10.035. Epub 2023 Jan 27.
引用本文的文献
1
Components of Mineralocorticoid Receptor System in Human DRG Neurons Co-Expressing Pain-Signaling Molecules: Implications for Nociception.共表达疼痛信号分子的人背根神经节神经元中盐皮质激素受体系统的组成成分：对伤害感受的影响
Cells. 2025 Jul 24;14(15):1142. doi: 10.3390/cells14151142.
本文引用的文献
1
Surgical Aortic Valve Replacement in Patients Aged 50 to 70 Years: Mechanical or Bioprosthetic Valve? A Systematic Review.50至70岁患者的主动脉瓣置换手术：机械瓣膜还是生物瓣膜？一项系统评价。
Healthcare (Basel). 2023 Jun 15;11(12):1771. doi: 10.3390/healthcare11121771.
2
Valvular Heart Disease Epidemiology.瓣膜性心脏病流行病学。
Med Sci (Basel). 2022 Jun 15;10(2):32. doi: 10.3390/medsci10020032.
3
Activation of the Interleukin-33/ST2 Pathway Exerts Deleterious Effects in Myxomatous Mitral Valve Disease.白细胞介素-33/ST2 通路的激活对黏液样变性性二尖瓣疾病产生有害影响。
Int J Mol Sci. 2021 Feb 25;22(5):2310. doi: 10.3390/ijms22052310.
4
A New Role for the Aldosterone/Mineralocorticoid Receptor Pathway in the Development of Mitral Valve Prolapse.醛固酮/盐皮质激素受体通路在二尖瓣脱垂发展中的新作用。
Circ Res. 2020 Jul 17;127(3):e80-e93. doi: 10.1161/CIRCRESAHA.119.316427. Epub 2020 Apr 24.
5
5-HT Receptor-Mediated Activation of ERK1/2 Requires Both Gα and β-Arrestin Proteins.5-HT 受体介导致 ERK1/2 的激活需要 Gα 和β-arrestin 蛋白。
ACS Chem Neurosci. 2019 Jul 17;10(7):3143-3153. doi: 10.1021/acschemneuro.8b00596. Epub 2019 Apr 29.
6
Serotonin contribution to cardiac valve degeneration: new insights for novel therapies?血清素对心脏瓣膜退行性变的影响：新型治疗方法的新见解？
Pharmacol Res. 2019 Feb;140:33-42. doi: 10.1016/j.phrs.2018.09.009. Epub 2018 Sep 9.
7
2017 ESC/EACTS Guidelines for the Management of Valvular Heart Disease.2017年欧洲心脏病学会/欧洲心胸外科学会心脏瓣膜病管理指南
Rev Esp Cardiol (Engl Ed). 2018 Feb;71(2):110. doi: 10.1016/j.rec.2017.12.013.
8
Serotonin receptor 2B signaling with interstitial cell activation and leaflet remodeling in degenerative mitral regurgitation.在退行性二尖瓣反流中，血清素受体 2B 信号与间质细胞激活和瓣叶重构有关。
J Mol Cell Cardiol. 2018 Feb;115:94-103. doi: 10.1016/j.yjmcc.2017.12.014. Epub 2017 Dec 30.
9
The role of 5-HT receptors in mitral valvulopathy: bone marrow mobilization of endothelial progenitors.5-HT 受体在二尖瓣瓣病中的作用：内皮祖细胞的骨髓动员。
Br J Pharmacol. 2017 Nov;174(22):4123-4139. doi: 10.1111/bph.13981. Epub 2017 Oct 15.
10
Valvular Heart Disease in Adults: Etiologies, Classification, and Diagnosis.成人心脏瓣膜病：病因、分类及诊断
FP Essent. 2017 Jun;457:11-16.
Zotero 插件